On August 26, 2021, Graham Walmsley, M.D., Ph.D., informed the Board of Directors (the Board") of ALX Oncology Holdings Inc. that he would resign from the Board effective August 26, 2021. In addition, in connection with Dr. Walmsley's resignation, director Jason Lettmann was appointed to the Audit Committee of the Board.